MARKET

EVOK

EVOK

Evoke Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.575
-0.025
-1.56%
Closed 16:00 01/17 EST
OPEN
1.600
PREV CLOSE
1.600
HIGH
1.600
LOW
1.550
VOLUME
128.26K
TURNOVER
--
52 WEEK HIGH
3.260
52 WEEK LOW
0.5001
MARKET CAP
38.17M
P/E (TTM)
-4.2361
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of EVOK and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

EVOK News

  • Evoke Resubmits Gimoti New Drug Application To FDA
  • Benzinga.12/20/2019 13:32
  • Evoke Resubmits Gimoti New Drug Application to FDA
  • GlobeNewswire.12/20/2019 13:30
  • Evoke Pharma Regains Compliance with Nasdaq Minimum Bid Requirement
  • GlobeNewswire.12/02/2019 13:30
  • Evoke Pharma up 32%
  • Seeking Alpha - Article.11/18/2019 20:50

More

Industry

Pharmaceuticals
+0.13%
Pharmaceuticals & Medical Research
+0.06%

Hot Stocks

Name
Price
%Change

About EVOK

Evoke Pharma, Inc. is a specialty pharmaceutical company. The Company is focused primarily on the development of drugs to treat gastrointestinal (GI) disorders and diseases. The Company is developing EVK-001, a metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. EVK-001 is a formulation of Metoclopramide drug, designed to provide systemic delivery of metoclopramide through intranasal administration. The Company has evaluated EVK-001 in a multicenter, randomized, double-blind, placebo-controlled parallel group, dose-ranging Phase IIb clinical trial. The Company has commenced a Phase III clinical trial of EVK-001 in female patients with symptoms associated with acute and recurrent diabetic gastroparesis. The Phase III clinical trial is a multicenter, randomized, double-blind, placebo-controlled, parallel-group study evaluating the efficacy, safety and population pharmacokinetics of EVK-001 in adult females.
More

Webull offers Evoke Pharma Inc (EVOK) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.